News
bluebird bio's Zynteglo has become the first cell-based gene therapy to be approved in the US, getting the nod from the FDA as a treatment for patients with beta thalassaemia who require regular ...
Bluebird’s lead CAR-T cancer cell therapy idecabtagene vicleucel (ide-cel) was last year hit with an FDA refuse-to-file letter, which required additional data on chemistry, manufacturing and ...
Blue Bird (BLBD) Surpasses Market Returns: Some Facts Worth Knowing The latest trading day saw Blue Bird (BLBD) settling at $42.88, representing a +2.17% change from its previous close.
View the latest Blue Bird Corp. (BLBD) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Blue Bird Showcases Zero- and Low-Emission Commercial Vehicle Platforms at 2025 Advanced Clean Transportation (ACT) Expo Business Wire Apr 30, 2025, 12:35:00 AM ...
Unicoi County Summer Count took place Saturday, June 14, with 15 observers in six parties. Sharp-eyed counters tallied 107 ...
Local bluebird enthusiasts recently gathered on Marietta Square to raise a toast and funds for the Bluebird Trail, a 13-year conservation effort to repopulate bluebirds in the southeast.
The Jays made a roster move: Will Wagner is back up with the team. Alan Roden is on his way to Buffalo. Roden wasn’t getting playing time anyway, so he might as well play in Buffalo. His line ...
Yankees 4 Blue Jays 5 That was an exciting game—lots of debatable moves, lots of good defense, bad defense (mainly by the Yankees). Max Scherzer looked excellent. He went five innings, gave up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results